Streetbeat News

Earnings

IMVT

Immunovant reported Q2 losses of $(0.45) per share, beating the analyst consensus estimate of $(0.48) by 6.25%. This is a 9.76% decrease over losses of $(0.41) per share from the same period last year. The company's pro forma cash and cash equivalent stands at $737M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:24 pm

TDG

TransDigm Group Incorporated (TDG) has issued its fiscal 2024 guidance, expecting net sales to be in the range of $7.48 billion to $7.68 billion, up from $6.585 billion in fiscal 2023. The company also anticipates net income from continuing operations to be between $1.641 billion and $1.753 billion, and adjusted earnings per share to be between $31.00 and $32.94. The guidance excludes any impact from the pending acquisition of the Electron Device Business of CPI.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:23 pm

XERS

Xeris Biopharma has expressed confidence in achieving cash flow breakeven in Q4.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:23 pm

TDG

TransDigm Group Incorporated has announced its Q4 results and declared a special cash dividend of $35.00 per share. The record date for the special dividend is November 20, 2023, and the payment date is November 27, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:20 pm

VVV

Valvoline has announced its expectation for FY24 adjusted EPS to be between $1.40-$1.65. The company also plans to add 140-170 stores to its network, with 55-70 of these coming from franchisees.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:19 pm

BHIL

Benzon Hill's Q3 203 earnings per share (EPS) of $(0.09) surpassed the estimated $(0.19). The company's revenue of $113.066M also exceeded the $87M estimate.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:19 pm

TDG

TransDigm Group reported Q4 earnings of $8.03 per share, beating the analyst consensus estimate of $7.53 by 6.64%. This is a 46% increase from the same period last year. The company also reported quarterly sales of $1.85 billion, beating the analyst consensus estimate of $1.83 billion by 1.09%. This is a 22.52% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:18 pm

VVV

Valvoline has projected its FY24 results to align with its long-term growth algorithm, expecting top line sales of $1.6B-$1.7B and an adjusted EBITDA of $420M-$460M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:18 pm

CMAX

CareMax has updated its FY23 Medicare Advantage membership guidance to approximately 110,000, down from the previous guidance of 110,000-120,000. The company also revised its forecast for adjusted EBITDA to $15M-$25M, down from the previous guidance of $25M-$35M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:16 pm

BKTI

BK Technologies reported Q3 earnings of $0.03 per share, a 104.29% increase YoY. The company also reported $20.07M in sales, a 68.41% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:16 pm